A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Efficacy and Usefulness of DPP4 Inhibitors in NIDDM Patients on the Backdrop of Metformin and Sulfonyl Urea
2022
International journal of pharmaceutical sciences review and research
Diabetes mellitus, sometimes known as diabetes, is a collection of metabolic illnesses defined by a persistently high blood sugar level. Diabetes, if left untreated, can lead to a slew of health issues. Diabetes is caused by either a lack of insulin production by the pancreas or a lack of insulin response by the body's cells. The purpose of the study is to investigate the efficacy of dipeptidyl peptidase 4 inhibitors (DPP-4 inhibitors) in individuals with type 2 diabetes mellitus who were
doi:10.47583/ijpsrr.2022.v74i01.012
fatcat:w33ddczvvngzhab7jth5ctwn3i